• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Pars Planitis

Pars Planitis - 5 Studies Found

Completed : Quality of Life in Patients With Intermediate Uveitis
: Macular Edema
: 2011-03-11
Completed : Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
: Uveitis
: 2010-05-14
:
  • Drug: Adalimumab Administered

Completed : Efficacy and Safety of Adalimumab in Patients With Active Uveitis
: Uveitis
: 2010-05-14
:
  • Biological: Adalimumab Adminis

Completed : Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients
:
  • Uveitis
  • Anterior Uveitis
  • Intermediat
    : 2016-04-25
    : Drug: H.P. ACTHAR SUBCUTANEOUS GEL INJECTION Subcutaneous injection twice weekly
Completed : Suprachoroidal Injection of CLS-TA in Subjects Non-infectious Uveitis
:
  • Uveitis
  • Uveitis, Posterior
  • Uveitis, Anterior
  • : 2017-03-27
    : Combination Product: 4mg CLS-TA Suprachoriodal Injection CLS-TA, 4 mg in 100 microliters, will be admini
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.